I got the same auto response a few days ago. I guess the glass-half-full way to look at it is that if someone at Calico really looked into anatabine citrate, that person might actually do a thorough job. Would Patrick Cox have any clout in this matter, do you think?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.